Add to ORKGWe studied 61 CD20 – B-cell lymphomas, including 29 cases of precursor B-cell lymphoblastic leukemia/lymphoblastic lymphoma (B-ALL/B-LBL), 25 cases of CD20 – recurrent mature B-cell lymphoma after rituximab therapy, and 7 cases of CD20 – diffuse large B cell lymphoma (DLBCL). We used marker
B-cell precursor acute lyphoblastic leukemia (ALL) is a common pediatric malignancy and patients may...
PubMedID: 21805377Rituximab (the chimeric anti-CD20 antibody) is widely used in the treatment of CD2...
Precursor B-cell lymphoblastic leukemia. Phenotype / cell stem origin The cell of origin is thought ...
We studied 61 CD20- B-cell lymphomas, including 29 cases of precursor B-cell lymphoblastic leukemia/...
Change of CD20 expression was examined in cases of diffuse large B-cell lymphoma (DLBCL). CD20 expre...
CD20 negative B cell non-Hodgkin lymphoma (NHL) is rare and accounts for approximately 1-2% of B cel...
Lymphoblasts in B-lymphoblastic leukemia/lymphoma are almost always positive for the B-cell markers ...
Diffuse large B cell lymphoma (DLBCL) is the most common form of lymphoma and is characterized by ma...
Abstract. Mature T-cell neoplasms are relatively uncommon, accounting for approximately 10 % of all ...
A b s t r a c t The diagnosis of B-cell chronic lymphoproliferative disorders is a great challenge w...
Rare cases of CD20+ T-cell lymphoma (TCL) have been reported, but the clinicopathologic spectrum of ...
an important role in diagnosis and classification of B-cell lymphoprolifera-tive disorders (BCLPDs)....
Introduction: Acute lymphoblastic leukemia is a lymphocyte malignancy characterized by clonal buildu...
International audienceHuman CD20 is a B-cell lineage-specific marker expressed by normal and leukemi...
A patient with fibrosing alveolitis developed a diffuse large B-cell (DLBC) lymphoma that expressed ...
B-cell precursor acute lyphoblastic leukemia (ALL) is a common pediatric malignancy and patients may...
PubMedID: 21805377Rituximab (the chimeric anti-CD20 antibody) is widely used in the treatment of CD2...
Precursor B-cell lymphoblastic leukemia. Phenotype / cell stem origin The cell of origin is thought ...
We studied 61 CD20- B-cell lymphomas, including 29 cases of precursor B-cell lymphoblastic leukemia/...
Change of CD20 expression was examined in cases of diffuse large B-cell lymphoma (DLBCL). CD20 expre...
CD20 negative B cell non-Hodgkin lymphoma (NHL) is rare and accounts for approximately 1-2% of B cel...
Lymphoblasts in B-lymphoblastic leukemia/lymphoma are almost always positive for the B-cell markers ...
Diffuse large B cell lymphoma (DLBCL) is the most common form of lymphoma and is characterized by ma...
Abstract. Mature T-cell neoplasms are relatively uncommon, accounting for approximately 10 % of all ...
A b s t r a c t The diagnosis of B-cell chronic lymphoproliferative disorders is a great challenge w...
Rare cases of CD20+ T-cell lymphoma (TCL) have been reported, but the clinicopathologic spectrum of ...
an important role in diagnosis and classification of B-cell lymphoprolifera-tive disorders (BCLPDs)....
Introduction: Acute lymphoblastic leukemia is a lymphocyte malignancy characterized by clonal buildu...
International audienceHuman CD20 is a B-cell lineage-specific marker expressed by normal and leukemi...
A patient with fibrosing alveolitis developed a diffuse large B-cell (DLBC) lymphoma that expressed ...
B-cell precursor acute lyphoblastic leukemia (ALL) is a common pediatric malignancy and patients may...
PubMedID: 21805377Rituximab (the chimeric anti-CD20 antibody) is widely used in the treatment of CD2...
Precursor B-cell lymphoblastic leukemia. Phenotype / cell stem origin The cell of origin is thought ...